Injectable Drug Industry Analysis in North America

Future Market Insights

Key Insight

The injectable drug industry analysis in north america is projected to grow from USD 223.6 billion in 2025 to USD 435.8 billion by 2035, at a CAGR of 6.9%. Antibiotics will dominate with a 20.3% market share, while intravenous (iv) injections will lead the route of administration segment with a 44.3% share.

October 25, 2025

Anurag Sharma

326 Pages

Cite this Report

Injectable Drug Industry Analysis in North America

https://www.futuremarketinsights.com/reports/injectable-drug-industry-analysis-in-north-america

License

Buy Now

Summary ToC Companies

Key Players

Amgen
Bayer
Boehringer Ingelheim International GmbH
Cipla Ltd
Eisai Co. Ltd
GSK
Hikma Pharmaceuticals PLC
Roche
Sandoz (Novartis AG)
Sun Pharmaceutical Industries Ltd
Takeda Pharmaceutical Company Limited
Berkshire Hathaway
Viatris Inc. (Mylan N.V)

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Injectable Drug Industry Analysis in North America

Key Players

Similar Industry Reports